These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6889416)

  • 1. Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties.
    Tang AH; Franklin SR
    Pharmacol Biochem Behav; 1983 Jun; 18(6):873-7. PubMed ID: 6889416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.
    Tang AH; Franklin SR
    J Pharmacol Exp Ther; 1983 Jun; 225(3):503-8. PubMed ID: 6864515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM; Devia C; Brocklehurst C
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcotic discrimination in pigeons.
    Herling S; Coale EH; Valentino RJ; Hein DW; Woods JH
    J Pharmacol Exp Ther; 1980 Jul; 214(1):139-46. PubMed ID: 6993656
    [No Abstract]   [Full Text] [Related]  

  • 7. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.
    Holtzman SG
    Psychopharmacology (Berl); 1982; 77(4):295-300. PubMed ID: 6813889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.
    White JM; Holtzman SG
    Psychopharmacology (Berl); 1983; 80(1):1-9. PubMed ID: 6408661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discrimination studies.
    Holtzman SG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):263-82. PubMed ID: 2859972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine, buprenorphine, pentazocine and nalorphine on acquisition and extinction of active avoidance responses in rats.
    Saha N; Datta H; Sharma PL
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):179-82. PubMed ID: 2286420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF; Tam SW; Cook L
    Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the opioid and nonopioid effects of cyclazocine.
    Calligaro D; Young GA; Khazan N
    Pharmacol Biochem Behav; 1988 May; 30(1):163-7. PubMed ID: 3174740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
    Steinfels GF; Alberici GP; Tam SW; Cook L
    Neuropsychopharmacology; 1988 Dec; 1(4):321-7. PubMed ID: 2855202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.
    Hirschhorn ID
    Psychopharmacology (Berl); 1977 Nov; 54(3):289-94. PubMed ID: 413147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.